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Enhanced green ﬂuorescent proteinTheHMG-Box transcription factor SOX2 is expressed inneural progenitor populations throughout the developing
and adult central nervous system and is necessary to maintain their progenitor identity. However, it is unclear
whether SOX2 levels are uniformly expressed across all neural progenitor populations. In the developing dorsal
telencephalon, two distinct populations of neural progenitors, radial glia and intermediate progenitor cells, are
responsible for generating a majority of excitatory neurons found in the adult neocortex. Here we demonstrate,
using both cellular and molecular analyses, that SOX2 is differentially expressed between radial glial and
intermediate progenitor populations. Moreover, utilizing a SOX2EGFP mouse line, we show that this differential
expression can beused to prospectively isolate distinct, viable populations of radial glia and intermediate cells for
in vitro analysis. Given the limited repertoire of cell-surface markers currently available for neural progenitor
cells, this provides an invaluable tool for prospectively identifying and isolating distinct classes of neural
progenitor cells from the central nervous system.niversity of North Carolina, 115
ax: +1 919 966 9605.
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Heterogeneous populations of neural progenitor cells, each with
distinct molecular and cellular characteristics, reside in neurogenic
regions throughout the developing mammalian central nervous
system (CNS). In the rodent dorsal telencephalon (dTel), two such
progenitor populations have been characterized. The ﬁrst population,
located primarily in the ventricular zone (VZ), consists of self-
renewing, multipotent radial glial cells (RGCs) that have the capacity
to generate both neurons and glia in vivo (Anthony et al., 2004;
Malatesta et al., 2003, 2000; Noctor et al., 2001). RGCs are also capable
of generating a second, transient neural progenitor population of
intermediate progenitor cells (IPCs; or basal progenitor cells) which,
in contrast to RGCs, reside in the subventricular zone (SVZ), are
exclusively neurogenic, and have limited self-renewal capacity
(Haubensak et al., 2004; Miyata et al., 2004; Noctor et al., 2004).
Interestingly, subtypes of both RGC and IPC populations have also
been observed in the dTel, including unipotential RGCs which are
exclusively neurogenic or gliogenic, as well as IPC subpopulations with
distinctmorphological characteristics (Gal et al., 2006; Kawaguchi et al.,
2008; Kowalczyk et al., 2009;Mizutani et al., 2007; Stancik et al., 2010).
Thus, the developing dTel harbors a diverse mixture of distinct
cellularly-deﬁned neural progenitor cell populations.The mechanisms which regulate neural progenitor cell diversity
include a variety of transcriptional networks (Guillemot, 2007). In the
dTel for instance, the interplay of several key transcription factors
deﬁnes and regulates the “radial glial–intermediate progenitor–neuron”
transition (Englund et al., 2005). RGCs express high levels of the paired-
domain protein PAX6 which is necessary to properly maintain their
radial glial identity (Gotz et al., 1998; Haubst et al., 2004; Heins et al.,
2002). IPCs, in contrast, downregulate PAX6 concomitant with the
upregulation of, among other genes, the proneural basic helix–loop–
helix transcription factor Neurogenin 2 (NGN2) and the T-Box
transcription factor 2 (TBR2), which specify neuronal and IPC fates,
respectively (Arnold et al., 2008; Bulfone et al., 1999; Englund et al.,
2005; Kimura et al., 1999; Miyata et al., 2004; Sessa et al., 2008). These
genes, in turn, are downregulated upon neuronal differentiation
coincident with the upregulation of neuronal subtype-speciﬁc genes
such as T-Box transcription factor 1 (TBR1)(Englundet al., 2005;Hevner
et al., 2001). Thus, the temporal and spatial gradient of expression of
these and other key transcription factors is important in regulating
neural progenitor cell fate in the dTel.
The SOXB1 transcription factor SOX2 is expressed in neural progenitor
cells throughout thedeveloping andadult CNS (Bani-Yaghoubet al., 2006;
Brazel et al., 2005; Cavallaro et al., 2008; Collignon et al., 1996; D'Amour
and Gage, 2003; Ellis et al., 2004; Favaro et al., 2009; Miyagi et al., 2008;
Uchikawaet al., 1999;Uwanoghoet al., 1995;WoodandEpiskopou, 1999;
Zappone et al., 2000). In the chick neural tube, SOX2 expression is
sufﬁcient to maintain cells in a neural progenitor state while its loss of
function induces cell cycle exit and precocious neuronal differentiation
(Bylund et al., 2003; Graham et al., 2003). In mice, in vivo hypomorphic
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an important role in neural progenitor cells. In the cortex, hypomorphic
levels of SOX2 result in decreases in both progenitor proliferation and
neuronal production (Cavallaro et al., 2008; Favaro et al., 2009; Ferri et al.,
2004), while in the retina, aberrant neuronal differentiation is observed
(Taranova et al., 2006). Moreover, hereditary eye and hippocampal
defects have also been attributed to hypomorphic SOX2 mutations in
humans (Bakrania et al., 2007; Fantes et al., 2003; Hagstrom et al., 2005;
Ragge et al., 2005; Sisodiya et al., 2006). Further evidence supporting a
dose-dependent role of SOX2 in the dTel comes from immunocytochem-
ical studies illustrating a gradient of SOX2 expression in the cortex (Bani-
Yaghoub et al., 2006) as well as in vitro studies which demonstrate that
SOX2-expressing cells are responsible for all neurospheres generated
from the telencephalon (D'Amour and Gage, 2003; Ellis et al., 2004) and
express high levels of “neural stem cell” genes such as Notch1 and Nestin
(D'Amour and Gage, 2003). Thus, these ﬁndings collectively suggest that
the intracellular concentration of SOX2 plays an important role in the
maintenance and differentiation of neural progenitor cells as a whole.
However, taking into consideration that multiple, distinct populations of
neural progenitor cells reside in theCNS, oftenwithin the same region (i.e.
dorsal telencephalon), these studies have failed to address an important
question—whether SOX2 is differentially expressed between distinct
neural progenitor populations in vivo.
To directly address this question, ﬁrst we characterize SOX2
expression inRGCand IPCs in thedTel andshowthat SOX2 isdifferentially
expressed between these two populations. In addition, we employ a
transgenic SOX2EGFP reportermouse line to illustrate that the prospective
isolation of RGCs, IPCs, and differentiated neurons from the developing
dTel can be accomplished based upon their differential expression of
SOX2. Thus, these results demonstrate that the intracellular concentration
of SOX2 varies between distinct classes of neural progenitor cells in the
dTel, which in turn can be utilized to efﬁciently identify and isolate
distinct populations of viable neural progenitor cells from the dTel for use
in both in vivo and in vitro investigations.
Materials and methods
Animals
All animalswere used andmaintained in accordancewith guidelines
published in theNIHGuide for the Care andUse of Laboratory Animals and
all protocols were approved by the Institutional Animal Care and Use
Committee at the University of North Carolina-Chapel Hill. The
generation of the SOX2EGFP mouse line has been described previously
(Ellis et al., 2004). SOX2EGFP/+ litters were generated by crossing
SOX2EGFP/+ male mice with C57Bl6 female mice (Jackson Laboratory).
Pregnant females were euthanized and the embryos harvested at
embryonic day (E)12.5 and E16.5 (plug date was recorded as E0.5).
Tissue dissociation, Fluorescence-Activated Cell Sorting (FACS), and
neurosphere assay
Tissue dissociation and neurosphere generation were conducted
using published protocols (Hutton and Pevny, 2008). In short, the dTel
was dissected from E16.5 SOX2EGFP/+ and SOX2+/+ embryos and
incubated in Papain (Roche) followed by treatments with Trypsin
Inhibitor (Sigma) and a ﬁnal wash with Neurobasal medium (Invitro-
gen). The tissue was then mechanically dissociated into a single-cell
suspension in supplemented Neurobasal medium (Invitrogen) contain-
ing B27 (Invitrogen) and N2 supplements (Invitrogen) and 10 ng/ml
bFGF and EGF (Invitrogen).
Fluorescent analysis and cell sorting were conducted at the
University of North Carolina Flow Cytometry Facility using a MoFlo
ﬂow cytometer (Beckman-Coulter) and Summit v4.3 software (Dako).
Freshly dissociated cells were maintained in supplemented Neuroba-
sal medium and kept on ice. EGFP-positive cells were sorted into threesubpopulations based upon the level of their ﬂuorescent intensity. The
top tenth percentile for intensity was considered EGFPHigh, 40–60th
percentile EGFPInt, and bottom tenth percentile EGFPLow. Immediately
after sorting, cell density was calculated using a hemacytometer.
To generate neurospheres, freshly isolated cells were seeded at a
clonal density of 2000 cells/6 cm dish (283 cells/cm2) (Coles-Takabe
et al., 2008; Hutton and Pevny, 2008). After 6 days in culture, the
number of neurospheres per dishwas counted. Individual neurospheres
were then isolated in single wells of 96-well, non-adherent plates and
their diametermeasured every 2 days using Image ProExpress Software
(Media Cybernetics). To generate secondary and tertiary neurospheres,
individual neurospheres were mechanically dissociated into single-cell
suspensions and then plated again at clonal density. For differentiation
analysis, individual neurospheres were plated in 8-well chamber slides
(Nunc) coatedwith Poly-D-Lysine and Laminin and allowed to attach for
24 h, after which the medium was replaced with Neurobasal medium
(+2% horse serum) lacking basic Fibroblast Growth Factor (bFGF) and
Epidermal Growth Factor (EGF). Neurospheres were then cultured for
1 week under these conditions at which time they were ﬁxed with 4%
paraformaldehyde (PFA) for 30 min at room temperature and stained
using the immunocytochemistry procedures below.
Quantitative RT-PCR
Isolated cells not used for the Neurosphere Assay were utilized for
gene transcriptome analysis. Total RNA was isolated from cell pellets
using Trizol Reagent (Invitrogen) and the concentration was deter-
mined using an ND1000 spectrophotometer (Nanodrop). cDNA was
then generated from 50 μg of total RNA using a Superscript First Strand
Synthesis Kit (Invitrogen). Quantitative real-time PCR reactions were
run on an ABI 7500 Fast Real-Time PCR System (Applied Biosystems)
using a SYBR Green labeling kit (Applied Biosystems). All samples were
run in triplicate andnormalized toGAPDHexpression.Primer sequences
are as follows: β-Tubulin III-F: 5′-tcacgcagcagatgttcgat-3′, β-Tubulin III-
R: 5′-gtggcgcgggtcaca-3′; BLBP-F: 5′-cgcaacctggaagctgaca-3′, BLBP-R:
5′-gcccagagctttcatgtactca-3′; EGFP-F: 5′-gccacaagttcagcgtgtcc-3′, EGFP-
R: 5′-gcttctcgttggggtctttgc-3′; Ngn2-F: 5′-cggcgtcatcctccaact-3′, Ngn2-
R: 5′ggctagcgggcgataaagt-3′; Notch1-F: 5′-ggatcacatggaccgattgc-3′,
Notch1-R: 5′-atccaaaagccgcacgatat-3′; PAX6-F: 5′-caggccctggttggtatcc-
3′, PAX6-R: 5′-ggtgttctctccccctcctt-3′; SOX2-F: 5′-cgcggcggaaaacca-3′,
SOX2-R: 5′-cctccgggaagcgtgtact-3′; SOX3-F: 5′-tgcggtgcacatgaagga-3′,
SOX3-R: 5′-tgagcagcgtcttggtcttg-3′; Tis21-F: 5′-cattacaaacaccactggtttc-
cag-3′, Tis21-R: 5′-gctggctgagtccaatctggctg-3′; TBR1-F: 5′-
ctcgctctttcacttgaccc-3′, TBR1-R: 5′-actcgactcgcctaggaaca-3′; TBR2-F:
5′-tgaatgaaccttccaagactcaga-3′, TBR2-R: 5′-ggcttgaggcaaagtgttgaca-3′;
GAPDH-F: 5′-tgtgtccgtcgtggatctga-3′ and GAPDH-R: 5′-cctgcttcac-
caccttcttga-3′.
Immunocytochemistry
Mouse embryos were ﬁxed in 4% paraformaldehyde (PFA) in
phosphate buffered saline (PBS) overnight at 4 °C. After ﬁxation, the
tissue was then sequentially immersed in a 10%, 20%, and 30% sucrose
gradient and ﬁnally embedded in OCT medium (Tissue-Tek). 12 μm
coronal sections were made using a cryostat and collected on
Superfrost Plus coated glass slides (VWR). Slides were blocked for
1 h at room temperature with 10% goat serum/1% Triton X-100 in PBS.
All primary and secondary antibodies were diluted in 5% goat serum/
0.1% Triton X-100 in PBS. Primary antibodies used are: SOX2 (1:2000
Millipore; 1:100 R&D Systems), PAX6 (1:100 Developmental Studies
Hybridoma Bank), TBR2 (1:500 AbCam), and β-Tubulin III (TUJ1,
1:1000 Covance). Goat secondary antibodies used for the detection of
primary antibodies were: anti-rabbit Alexa 488 or 546 (1:1000
Invitrogen) and anti-mouse (IgG1 and IgG2A) Alexa 488, 546, and 647
(1:1000 Invitrogen). Fluorescent images were obtained using a Leica
Microsystems (Wetzlar, Germany) DM-IRB inverted ﬂuorescent
Fig. 1. Immunocytochemical characterization of SOX2-positive cells in the E16.5 dorsal
telencephalon. (A–G) Triple-labeling of SOX2, PAX6, and TBR2 in the VZ and SVZ. White
arrowheads show cells co-expressing high levels of SOX2 and TBR2. White arrows
indicate cells co-expressing all three transcription factors while red arrows label cells
that co-express PAX6 and TBR2 but not SOX2. (H) SOX2 expression is largely exclusive
of β-Tubulin III expression, although SOX2-positive, β-Tubulin III-positive cells are
found intermittently throughout the VZ and SVZ (asterisks). Scale bar=50 μm (A–G);
25 μm (H). Abbreviations: VZ, ventricular zone; SVZ, subventricular zone and BV, blood
vessel.
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using Image Pro Express software (Media Cybernetics).
Cell counting
For cell count comparisons, 12 μm coronal sections were stained for
cell-speciﬁc antibodies and counterstained with Hoechst 33258 to label
nuclei. Pictureswere taken at 20×magniﬁcation and a 300 μm×300 μm
box was drawn over the dorsal telencephalon using Photoshop
software. Cells double-labeled for both Hoechst and antibody were
then counted. Four consecutive slices were measured for each embryo
(n=4 embryos/genotype).
Statistical analysis
All data were statistically analyzed using Prism 3.0 software
(GraphPad). Samples were analyzed using One-Way ANOVA and
post-hoc analysis was conducted using Tukey's range test.
Results
Sox2 is highly expressed in radial glial cells and at lower levels in
intermediate progenitor cells
To molecularly characterize progenitor populations in the dTel, we
triple labeled E16.5 coronal sections with SOX2, PAX6, and TBR2.
SOX2 is highly expressed in the VZ and at lower levels in the SVZ
(Fig. 1A). In comparison, the RGC marker PAX6 (Anthony et al., 2004;
Malatesta et al., 2003, 2000; Noctor et al., 2001) shows a similar
expression pattern in the VZ and SVZ (Fig. 1B) and amajority of SOX2-
positive cells (94.8%±3.01) within the VZ co-express PAX6 (Fig. 1C),
demonstrating that RGCs express high levels of both transcription
factors. Next, we compared SOX2 and PAX6 expression with that of
the IPCmarker TBR2 (Arnold et al., 2008; Bulfone et al., 1999; Englund
et al., 2005; Kimura et al., 1999; Sessa et al., 2008). TBR2-positive IPCs
predominantly reside in the SVZ (Fig. 1D) and express low levels of
SOX2 (Fig. 1E), although a subset of TBR2-positive cells expressing
high levels of SOX2 are found scattered throughout the VZ/SVZ
boundary which, based upon their location, we presumed to be newly
generated IPCs migrating out of the VZ (Fig. 1E, arrowheads).
Similarly, 99% (98.8%±0.06%) of TBR2-positive IPCs express PAX6,
with SVZ IPCs expressing low levels of PAX6 and scattered VZ IPCs
expressing high levels of PAX6 (Fig. 1E and F, arrows), consistent with
previously studies (Englund et al., 2005). Interestingly, SOX2 was not
expressed in all TBR2-positive; PAX6-positve IPCs (Fig. 1G, red
arrows). These data demonstrate that both SOX2 and PAX6 are
maintained at high levels in RGCs, but at lower levels in TBR2-positive
IPCs. Lastly, most SOX2-positive cells were mutually exclusive of β-
Tubulin III-positive neurons throughout the dTel (Ellis et al., 2004;
Zappone et al., 2000), although SOX2-positive; β-Tubulin III-positive
cells were intermittently found in the VZ and SVZ (Fig. 1H, asterisks).
Distinct neural progenitor populations can be prospectively isolated
based upon SOX2 expression levels
Our immunocytochemistry results indicate that SOX2 is differen-
tially expressed between RGC and IPC populations. To more accurately
ascertain whether the level of SOX2 expression can be used to identify
distinct neural progenitors, we isolated populations of neocortical
progenitor cells based upon their level of SOX2 expression and analyzed
the gene expression proﬁle as well as the self-renewal and differenti-
ation capacity of each sorted population. To this end, we utilized the
SOX2EGFP mouse line in which an enhanced green ﬂuorescent protein
(EGFP) expression cassette is inserted into the SOX2 locus using
homologous recombination, faithfully recapitulating endogenous SOX2
expression in the CNS (Ellis et al., 2004). In the SOX2EGFP/+ dTel, SOX2 isexpressed in the VZ and SVZ of the lateral ventricles (Fig. 2A). EGFP is
similarly expressed in the VZ and SVZ, but is also observed in the more
superﬁcial layers, a difference we attribute to the increased stability of
the EGFP protein (Fig. 2B) (Cubitt et al., 1995). Thus, the coexpression of
endogenous SOX2 with EGFP (Fig. 2B, inset) allows for the prospective
isolation of progenitor cells based upon SOX2–EGFP expression levels.
We ﬁrst compared EGFP intensity proﬁles of SOX2EGFP/+ dorsal
telencephalic cells isolated from early (E12.5) and late (E16.5) periods of
neurogenesis using ﬂow cytometry. We hypothesized that at E12.5,
when RGCs are the predominant progenitor populations in the dTel
(Hartfuss et al., 2001; Malatesta et al., 2003, 2000), cells would express
high EGFP intensity levels. In contrast, at E16.5 when RGCs, IPCs, and
post-mitotic neurons constitute the dTel (Hartfuss et al., 2001;Malatesta
et al., 2003, 2000), we would observe a shift towards lower EGFP
Fig. 2. Expression proﬁle of the SOX2EGFP mouse line using ﬂow cytometry. (A–B) Coronal
sections of E16.5 SOX2EGFP/+ mice labeled with an anti-SOX2 antibody and expressing
endogenousEGFPdrivenby theSOX2promoter. (B, inset) Theboxed regionsof panelsA and
B showcells that co-express anti-SOX2andEGFP locatedwithin theVZ andSVZof thedorsal
telencephalon. (C) Dissociated cells from E12.5 and E16.5 SOX2EGFP/+ dorsal telencephalon
were analyzed for EGFP intensity usingﬂow cytometry. E12.5 SOX2EGFP/+ intensity proﬁle is
in green and E16.5 SOX2EGFP/+ intensity proﬁle in red. Cells from SOX2+/+ animals (gray)
were used as an EGFP-negative control. Abbreviations: EGFP, enhanced green ﬂuorescent
protein; VZ, ventricular zone and SVZ, subventricular zone. Scale bars: (A–B)=250 μm.
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mitotic neurons, respectively. In both E12.5 and E16.5 SOX2EGFP/+ mice,
EGFP-positive cells can be distinguished from SOX2+/+:EGFP-negative
littermate controls using ﬂow cytometry (Fig. 2C, red and green vs. gray).
At E12.5, dorsal telencephalic progenitor cells express high levels of EGFP
(871.3±31.44 ﬂuorescent units) and display anormal distribution curve
(Fig. 2C, green) consistentwith a uniform population of RGCs expressing
high levels of SOX2. In contrast, the E16.5 cells, on average, express lower
levels of EGFP compared with E12.5 cells (306.8±26.24 ﬂuorescent
units) (Fig. 2C, red). However the E16.5 intensity proﬁle is skewed,
suggesting that, even though a majority of E16.5 cells express low levels
of EGFP, a small population of cells is maintained that expresses EGFP
levels equivalent to those levels observed in E12.5 embryos (Fig. 2C, red).
These results demonstrate that RGCs expressing high levels of SOX2 (as
indicated by EGFP expression) are found in the dTel during both early
(~E12.5) and late (~E16.5) stages of neurogenesis whereas IPCs
expressing low levels of SOX2areonlyobservedat later stages. Therefore,
we next determined whether these populations can be prospectively
separated based upon their levels of SOX2–EGFP expression.
Neurosphere size, self-renewal, and multipotency correlate with high
levels of SOX2 expression
Based upon our immunocytochemical and ﬂow cytometry results,
we hypothesized that RGCs express higher amounts of SOX2 (and
SOX2–EGFP) than IPCs, and therefore this differential expression can be
utilized to isolate viable populations of each cell type. Using Fluores-
cence-Automated Cell Sorting (FACS), we separated E16.5 EGFP-
positive cells from SOX2EGFP/+ embryos into three subpopulations
based upon their EGFP intensity levels: EGFPHigh, EGFPInt, and EGFPLow.
Post-sort analyses conﬁrmed that each subpopulation was distinct in
regard to its intensity of EGFPﬂuorescence (Fig. 3A) and analyses of Sox2
and Egfp mRNA transcript levels utilizing quantitative reverse tran-
scription polymerase chain reaction (qRT-PCR) demonstrate that both
Sox2 and Egfp mRNA transcript levels correspond to their respective
EGFP ﬂuorescent intensity levels (Fig. 3B).Next, the stem cell capacity of each subpopulation was analyzed
using the in vitro neurosphere assay (Hutton and Pevny, 2008; Reynolds
and Weiss, 1992). To ﬁrst test the capacity of EGFPHigh, EGFPInt, and
EGFPLow populations to generate neurospheres, freshly sorted cells from
each subpopulation were plated at clonal density (282.9 cells/cm2) and
cultured for 6 days (Coles-Takabe et al., 2008). All three subpopulations
generated EGFP-positive neurospheres (Fig. 3C–D), however EGFPLow
cells produced statistically fewer neurospheres compared to EGFPHigh
and EGFPInt subpopulations (Fig. 3C). In contrast, EGFP-negative cells
isolated fromSOX2EGFPdTelwere unable to produceneurospheres (data
not shown). Moreover, EGFPHigh cells produced larger diameter neuro-
spheres compared to EGFPInt and EGFPLow populations, suggesting a
difference in neurosphere growth rate (Fig. 3D–E). To directly examine
neurosphere growth, neurospheres were isolated from bulk cultures at
6 days in vitro (DIV) and individually maintained in 96-well plates to
prevent aggregation. The diameter of individual neurospheres was then
measured every 2 days. At 6 DIV, EGFPHigh cells produced signiﬁcantly
larger neurospheres than both EGFPInt and EGFPLow cells and these
differencesweremaintained throughout the culture periodup to10 DIV
(Fig. 3E). To better gauge the neurosphere size variation within each
subpopulation, neurosphereswere classiﬁed intooneof three categories
based upon their diameter at 6 DIV. The proportion of small-diameter
neurospheres (b100 μm) was signiﬁcantly greater in EGFPLow cultures
compared to both EGFPHigh and EGFPInt subpopulations (Fig. 3F). In
contrast, intermediate sized neurospheres (100–200 μm) were more
prevalent in the EGFPHigh and EGFPInt subpopulations (Fig. 3F).
Moreover, the EGFPHigh cultures also contained a signiﬁcant percentage
of large-diameter spheres (N200 μm) compared to both EGFPInt and
EGFPLow populations (Fig. 3F). These data thus demonstrate that cells
with high levels of SOX2–EGFP have an increased neurosphere forming
potential and growth rate.
Next, to analyze self-renewal potential, individual primary neuro-
spheres from EGFPHigh, EGFPInt, and EGFPLow cultures were dissociated
and allowed to form secondary, followed by tertiary, neurospheres
(Coles-Takabe et al., 2008; Hutton and Pevny, 2008). EGFPHigh primary
neurospheres generated signiﬁcantly more secondary and tertiary
neurospheres than both EGFPInt and EGFPLow primary neurospheres
(Fig. 4A). Moreover, EGFPLow primary neurospheres produced very few
secondary neurospheres and were unable to generate any tertiary
neurospheres (Fig. 4A), suggesting they have amore restricted capacity
for self-renewal. These data indicate that cellswith high levels of SOX2–
EGFP expression have an increased capacity for self-renewal.
Lastly, to test the multipotent differentiation capacity of the EGFPHigh,
EGFPInt, and EGFPLow subpopulations, primary neurospheres from each
subpopulation were induced to differentiate after 10 DIV. Multipotential
neurospheres, capable of generating both β-Tubulin III-positive neurons
and GFAP-positive astrocytes, were observed in each subpopulation with
EGFPHigh cells generating more multipotential neurospheres (89.2±
2.63%) compared to either EGFPInt (86.5±1.73%) or EGFPLow (62.3±
6.63%) cells (Fig. 4B and D) In addition, unipotent neurospheres, gener-
ating only β-Tubulin III-positive neurons, were identiﬁed in all three
populations (Fig. 4B and E). However, both EGFPInt and EGFPLow cells
generatedmoreunipotent neurospheres thanEGFPHigh cellswith EGFPLow
cells generating the most unipotent neurospheres of all three subpopula-
tions (Fig. 4B). Interestingly, we found that the multipotent capacity of a
neurospherewas correlatedwith its size, regardless of sorting population
(Fig. 4B–C). At 10 DIV, neurospheres with small diameters (b150 μm)
only generated neurons, while large neurospheres (N150 μm) generated
both neurons and glia.Wedidnot observe any glial-speciﬁc neurospheres
using these culture conditions.
EGFPHigh, EGFP Int, and EGFPLow populations express molecular markers
of radial glia, intermediate progenitors, and neurons, respectively
The results from our in vitro studies demonstrate that the EGFPHigh,
EGFPInt, and EGFPLow sortedpopulations eachhavedistinct proliferative,
Fig. 3. Generation and analysis of primary neurospheres. In vitro analyses of cells isolated based upon SOX2–EGFP intensity levels. (A) Representative EGFP intensity proﬁle of
EGFPHigh, EGFPInt, and EGFPLow subpopulations isolated from E16.5 dorsal telencephalon (n=4 for each sort). (B) Sox2 and EgfpmRNA transcript levels from EGFPHigh, EGFPInt and
EGFPLow sorted cells (N=3 separate sorting experiments). Fold difference is relative to EGFPHigh values for each gene. (C) Number of neurospheres formed per 2×103 cells plated
from EGFPHigh, EGFPInt and EGFPLow sorted cells. EGFPLow values are signiﬁcantly different (pb0.001(***)). (D) Representative images of EGFPHigh, EGFPInt and EGFPLow primary
neurospheres after 6 days in culture. Scale bars=75 μm. (E) Mean neurosphere diameters over 8 days of culturing. All values were signiﬁcantly different (pb0.001(***)).
(F) Percentage of primary neurospheres from each subpopulation after separation into one of three categories based upon diameter: small (100 μm), medium (100–200 μm) and
large (N200 μm). P values: pb0.05 (*) and pb0.01(**).
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neurosphere forming potential of the EGFPLow cells shows that this
population consists primarily of post-mitotic neurons while the
signiﬁcant differences in neurosphere size and self-renewal capacity
between the EGFPHigh and EGFPInt subpopulations indicate that these
two subpopulations of cells contain distinct neural progenitor popula-
tions as well.
We next addressed whether EGFPHigh, EGFPInt, and EGFPLow cells
could be molecularly distinguished by utilizing qRT-PCR to determine
transcript levels of ubiquitously expressed and neural cell type speciﬁc
genes. Sox3, a SOXB1 homologue which is coexpressed with Sox2 in
neocortical progenitor cells (Collignon et al., 1996; Uwanogho et al.,
1995; Wood and Episkopou, 1999), shows a similarly dynamic
regulation and its levels directly correlate with those of Sox2 (Fig. 5A).
Moreover, Notch1, a known effector of SOX2 which is highly expressed
in neural progenitor cells, was high in both EGFPHigh and EGFPInt
populations, but low in EGFPLow cells (Fig. 5A) (Mizutani et al., 2007).
These data show that both the EGFPHigh and EGFPInt subpopulations are
enriched for neural progenitor cells compared to EGFPLow cells.
These results demonstrate that the EGFPHigh subpopulation gen-
erates more self-renewing, multipotential, large-diameter neuro-
spheres than EGFPInt and EGFPLow cells, suggesting that the EGFPHigh
population consists of a larger proportion of stem cell like radial glial
cells.We conﬁrmed this by analyzing Brain Lipid Binding Protein (Blbp)
expression, a marker of radial glial (Hartfuss et al., 2001), and ﬁnd that
EGFPHigh cells express higher levels of Blbp transcript than both EGFPInt
and EGFPLow populations (Fig. 5A). In contrast, Pax6 transcript levels are
not only high in EGFPHigh cells but also in EGFPInt cells as well (Fig. 5A).
Given that Pax6 is widely used as a RGC marker, this result was
unexpected. However, these results are supported by recent ﬁndingsthat lower levels of Pax6maintain the progenitor identity of RGCswhile
higher Pax6 levels are necessary to promote IPC formation (Sansom
et al., 2009). Thus, our data demonstrate that EGFPHigh populations are
enriched for RGC progenitor cell markers and suggest that the EGFPInt
populations may contain IPCs.
EGFPInt cells generate smaller neurospheres with limited self-
renewal capacity. To address whether EGFPInt cells are enriched for
IPC molecular markers, transcript levels for IPC genes Tbr2 and Ngn2
(Englund et al., 2005; Miyata et al., 2004), as well as the neuronal-fate
marker Tis-21 (Iacopetti et al., 1999) were analyzed. Tbr2 and Ngn2
levels were signiﬁcantly higher in the EGFPInt subpopulation compared
to EGFPHigh cellswhile EGFPLow cells, in contrast, expressed low levels of
both transcripts (Fig. 5B). Similarly, in EGFPInt cells, Tis-21 was more
than 2-fold higher than EGFPHigh cells (Fig. 5B). Consistent with Tis-21
expression in cells undergoing a neuronal transition, higher levels of Tis-
21 are also observed in EGFPLow cells compared to EGFPHigh cells
(Iacopetti et al., 1999). Thus, these results show that cells expressing
intermediate levels of SOX2–EGFP are enriched for IPC markers.
Lastly, the low neurosphere forming potential of EGFPLow cells
suggests that these cells have lost the capacity to proliferate and
consist largely of post-mitotic neurons. We therefore examined the
expression of two neuronal genes, β-Tubulin III, which labels
immature neuronal cells, and Tbr1, which marks mature neuronal
populations (Fig. 5C). Indeed, both β-Tubulin III and Tbr1 transcript
levels were higher in EGFPLow cells compared to EGFPHigh and EGFPInt
populations and were slightly higher in EGFPInt cells compared to
EGFPHigh cells, suggesting that some cells from the EGFPInt sort have
undergone neuronal differentiation. Interestingly, detectable levels of
β-Tubulin III transcript are observed in EGFPHigh cells, whereas Tbr1
transcript is not, suggesting that a small population of EGFPHigh cells
Fig. 4. Functional analyses of neurosphere self-renewal andmultipotency. (A) Percentage
of EGFPHigh, EGFPInt and EGFPLow primary neurospheres capable of generating secondary
and tertiary neurospheres (n=16 neurospheres/condition). Signiﬁcant differences in
secondary and tertiary neurosphere generation were observed between all three
populations. P values: pb0.05 (*), pb0.01(**) and pb0.001(***). (B) The percentage of
primary neurospheres from each subpopulation that produce neurons and glia
(multipotential) or neurons only (unipotential). No glial-speciﬁc neurospheres were
observed. (C) The percentage of primary neurospheres from each subpopulation that
contained large-diameter (N150 μm) and small-diameter (b150 μm) neurospheres. (D)
Differentiated multipotential neurosphere labeled with β-Tubulin III (neurons), GFAP
(astrocytes), and the nuclear marker Hoechst 33258. (E) Example of a differentiated
unipotential neurosphere which generates β-Tubulin III-positive neurons only.
Fig. 5. Quantitative RT-PCR analyses of EGFPHigh, EGFPInt, and EGFPLow cells isolated
from E16.5 SOX2EGFP/+ dorsal telencephalon (N=3 separate sorting experiments).
(A) mRNA transcript levels for neural progenitor markers Sox3 and Notch1 and radial
glial markers Blbp and Pax6. (B) mRNA transcript levels for intermediate progenitor cell
markers Tbr2 and Ngn2 and the marker of neuronal-fated cells, Tis21. (C) mRNA
transcript levels for neuronal markers β-Tubulin III and Tbr1. Abbreviations: EGFP,
enhanced green ﬂuorescent protein; BLBP, Brain Lipid Binding Protein and NGN2,
Neurogenin 2.
45S.R. Hutton, L.H. Pevny / Developmental Biology 352 (2011) 40–47may also be generating immature neurons (see also Fig. 1H). Overall,
these results support our hypothesis that cells expressing low levels of
SOX2 and EGFP are enriched for post-mitotic neurons.Discussion
In comparison to other mammalian progenitor populations, neural
progenitor cells remain largely uncharacterized. This is due, in part, to
a lack of cell-surface markers available to identify and isolate distinct
neural progenitor populations from the nervous system. One marker,
the surface antigen CD133 (Prominin1), has been used extensively in
the isolation and analysis of neural progenitor cells from human
(Uchida et al., 2000) and mouse nervous system tissues (Corti et al.,
2007; Lee et al., 2005). The cell-surface marker CD15 (SSEA-1, LeX)
has also been used to isolate neural progenitor cells from mouse
(Capela and Temple, 2002) and has been shown to be expressed by a
subset of radial glial cells (Mai et al., 1998). However, neither CD133
nor CD15 expression is restricted to the nervous system as both are
expressed in progenitor cells from other tissues as well (Fox et al.,
1981; Gomperts et al., 1994; Jiang et al., 2002; Mizrak et al., 2008;
Solter and Knowles, 1978). Moreover, it was recently reported that
clonogenic, tripotent cells lacking CD133 and CD15 can be isolatedfrom neural stem cell cultures (Sun et al., 2009). Thus, the isolation of
viable neural progenitor cells based upon the expression of CD133 and
CD15 is not sufﬁcient and additional methods of identifying and
isolating neural progenitor cells are necessary.
To date, SOX2 is found to be expressed in all stem/progenitor
populations throughout the CNS, as well as other non-neural popula-
tions such as the stomach, lung, hair follicle and tongue (Driskell et al.,
2009; Ishii et al., 1998;Okubo et al., 2006; Pevny and Placzek, 2005; Que
et al., 2007). In the CNS, all neurosphere forming cells express SOX2
(Ellis et al., 2004) suggesting that, unlike CD133 and CD15, SOX2 is
constitutively expressed in neural progenitor cells. The recent genera-
tion of mouse lines expressing the EGFP reporter protein under the
control of the Sox2 promoter has therefore provided a valuable tool in
the characterization of neural progenitor cells (D'Amour and Gage,
2003; Ellis et al., 2004). Previously, D'Amour and Gage (2003) enriched
for neural progenitor cells by selectively isolating SOX2–EGFP-positive
cells from the telencephalon using FACS and also found that SOX2 levels
varied dependent upon EGFP intensity. However, the authors catego-
rized all SOX2–EGFP-positive cells from the telencephalon as a single
cohort of “neural stem cells” rather than a collection of cellular and
molecularly distinct populations of neural progenitor cells and therefore
they did not address whether these distinct populations differentially
express SOX2. It is also important to note that the particular mouse
SOX2–EGFP mouse line used by D'Amour and Gage (2003) does not
completely recapitulate endogenous SOX2 expression as EGFP is not
expressed in all neural progenitor cells due to the exclusion of select
Sox2 regulatory domains in the randomly integrated transgenic
construct (D'Amour and Gage, 2003; Zappone et al., 2000). In contrast,
in this study we utilize a SOX2EGFP mouse line in which the SOX2 open
reading frame has been directly replaced, using homologous recombi-
nation at the Sox2 locus, with an EGFP expression cassette (Ellis et al.,
2004). We ﬁnd that all neurosphere generating cells from the
developing dTel express SOX2 and moreover, we demonstrate the
power of this genetic tool in the characterization of neural progenitor
populations by isolating and enriching for subtypes of neocortical cells
based upon their level of SOX2 expression.
46 S.R. Hutton, L.H. Pevny / Developmental Biology 352 (2011) 40–47Our results demonstrate that RGCs in the dTel express high
intracellular levels of SOX2. Isolated cells expressing high levels of
SOX2 and EGFP (EGFPHigh) produced a greater number of large-
diameter, multipotential neurospheres compared with EGFPInt and
EGFPLow cells. Furthermore, these cells were enriched for radial glial
markers such as BLBP and neural progenitor markers such as SOX3 and
Notch1. In situ, SOX2 is also highly expressed in radial glial cell bodies in
the VZ andwas largely coexpressedwith PAX6 in these cells. In addition
to prospectively isolating radial glial populations, we are able to utilize
SOX2 expression levels to distinguish between IPCs and differentiated
neurons. EGFPInt cells express intermediate levels of EGFP and SOX2 and
are highly enriched for the bHLHproneural geneNgn2, the intermediate
progenitormarker Tbr2, and the neuronal-fatemarker Tis-21. However,
although these cells can generate neurospheres, they are smaller and
less likely to bemultipotent compared to EGFPHigh neurospheres. These
observations correspond to our in situ data inwhichmost TBR2-positive
intermediate progenitors express very low levels of SOX2 protein. In
contrast, EGFPLow cells rarely generate neurospheres and are enriched
for neuronal markers β-Tubulin III and TBR1, demonstrating that these
cells are differentiated neurons.
The observation thatmany of the EGFPInt and EGFPLow neurospheres
were multipotent was surprising, given the enrichment of IPC and
neuronal markers in these populations; however the results were not
altogether unexpected. By sorting cells based solely upon a continuum
of SOX2–EGFP expression, overlap between distinct cell populations
was unavoidable. However, these results are more likely the result of
inherent limitations of the culture system as the in vitro neurosphere
culture system does not completely recapitulate the in vivo neural
progenitor niche of the animal (reviewed in (Jensen andParmar, 2006)).
Previous studies have demonstrated that the regional identity of cells
can change under neurosphere culture conditions with progenitor cells
from the dorsal telencephalon acquiring a ventral progenitor identity
after culturing as neurospheres (Abematsu et al., 2006; Hack et al.,
2004). Moreover, the differentiation potential of neural progenitor cells
has been shown to change when cultured in vitro. For example, the
presence of bFGF, a necessary component of the neurosphere culture
medium, is able to convert bipotent spinal cord neural progenitor
cells to a tripotent state in vitro (Gabay et al., 2003). The presence of
multipotential neurospheres, especially in the EGFPInt population, may
suggest that while in vivo these cells are neuronally-speciﬁed, in vitro
they are capable of generating both neurons and glia. Moreover we
hypothesize that progenitor cells that are too far along the neuronal
differentiation “process” are unable to (re)acquire their multipotential
state, instead forming the small, neuronal unipotent neurospheres
enriched in our EGFPInt and EGFPLow cultures.
In these studies, we utilized the SOX2EGFP/+ mouse line in which
endogenous SOX2 expression levels are approximately 50% of wildtype
controls (Taranova et al., 2006). Although we cannot exclude the
possibility that our functional and molecular analyses are inﬂuenced by
the lower levels of initial SOX2 expression, our lab and others have
generated multiple SOX2 heterozygous mouse lines which genetically
demonstrate that heterozygous levels of SOX2 are sufﬁcient for proper
nervous system development (Avilion et al., 2003; Ellis et al., 2004;
Taranova et al., 2006) and defects in neural progenitor cells are only
observedwhen SOX2 levels drop to 20–30% ofwildtype levels (Cavallaro
et al., 2008; Ferri et al., 2004; Taranova et al., 2006). However, it remains
unclear if SOX2 levels directly inﬂuence the normal RPC–IPC–Neuron
transition.Mice harboring hypomorphicmutations in SOX2 have shown
decreases in cell-proliferation and neuronal differentiation, in addition
to defects in neuronal maturation, in the cortex (Cavallaro et al., 2008;
Favaro et al., 2009; Ferri et al., 2004; Miyagi et al., 2008; Taranova et al.,
2006). Moreover, overexpression of SOX2 in neurosphere cultures
inhibits neurogenesis while permitting gliogenesis (Bani-Yaghoub et al.,
2006; Bylund et al., 2003; Graham et al., 2003). These data suggest that
the precise regulation of SOX2 levels plays an important role in neural
progenitor fate speciﬁcation. If SOX2 expression is too high, neurogen-esis is inhibited; however, if neural progenitors fail to reach a certain
threshold of SOX2 expression (i.e. SOX2 hypomorphic mice), neurons
are unable to properly differentiate (Avilion et al., 2003; Bani-Yaghoub
et al., 2006; Bylund et al., 2003; Cavallaro et al., 2008; Graham et al.,
2003). Our data support a hypothesis in which a precisely regulated
decrease in SOX2 expression therefore is important for the proper RG–
IPC–Neuron transition in the dorsal telencephalon.
Conclusion
The identiﬁcation and characterization of neural progenitor popula-
tions in vivo have been hindered due to a limited number of available
cell-speciﬁcmarkers. Our results demonstrate that one suchmarker, the
transcription factor SOX2, is differentially expressed between radial glia,
intermediate progenitors, and differentiated neurons within the dorsal
telencephalon. Furthermore, utilizing the SOX2EGFP mouse line (Ellis
et al., 2004), we are able to prospectively isolate and enrich for these
populations based upon SOX2–EGFP intensity levels, thus providing a
powerful tool for the isolation of distinct, viable neural progenitor
populations from the CNS.
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